| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
																	Evercore ISI Group analyst Elizabeth Anderson maintains Teladoc Health (NYSE:TDOC) with a In-Line and lowers the price targe...
																	Teladoc Health (NYSE:TDOC) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.27) ...
																	Teladoc Health (NYSE:TDOC) is looking for Q4 GAAP EPS of $(0.25)-$(0.10) vs $(0.17) analyst estimate. sees sales of $622.000 mi...
																	Teladoc Health (NYSE:TDOC) narrows FY2025 GAAP EPS guidance from $(1.35)-$(1.00) to $(1.25)-$(1.10) vs $(1.12) analyst estimate...
																	Teladoc Health (NYSE:TDOC) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.26...
																	
																	
																	Investors are gearing up for a jam-packed week of earnings featuring several big tech names and retail-trader favorites.
																	In conjunction with this leadership announcement, Teladoc Health reaffirmed its 2025 full-year consolidated revenue and adjuste...